Note: I have no conflicts of interest with Nektar
Autoimmune diseases, pathologically characterized by the immune system's aberrant recognition and assault upon autologous tissues, represent intricate and multifactorial disorders. These conditions frequently arise from a dysfunctional interplay or compromised efficacy of intrinsic immunoregulatory mechanisms, often conceptualized as "immune checkpoints" or "brakes," thereby permitting an unconstrained escalation of immune activation. Rezpegaldesleukin (Rezpeg), a meticulously designed and strategically engineered cytokine analog, introduces a novel therapeutic paradigm. Its overarching objective is the precise re-establishment of immunological homeostasis, fundamentally diverging from conventional, broadly immunosuppressive intervention strategies. Rezpeg is specifically calibrated to engage and potentiate these pivotal regulatory mechanisms.
Molecular Design: Targeting Immunoregulatory T-Cell Subsets
The foundational principle underpinn…
